Vitros chemistry and immunoassay analyzer testing reagents and consumables
Ended Awarded Last action
- Contract number
- HT941026FE020
- Awardee
-
Ortho Clinical Diagnostics K.K. UEI E35NFBSEY3X4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $17,256
Award facts
- Contract value 100% obligated
- $17,255.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $17,255.88 blanket purchase agreement (BPA) call to Ortho Clinical Diagnostics K.K. for VITROS chemistry and immunoassay analyzer testing reagents and consumables. This firm fixed-price contract, awarded on January 28, 2026, with a completion date of February 13, 2026, supports clinical laboratory diagnostic operations at U.S. military medical facilities throughout Japan. The award carries no socioeconomic set-aside designation and represents a delivery order under an existing BPA vehicle with the Defense Health Agency valued at $2.875 million (effective July 1, 2024, through June 30, 2029) for chemistry and immunoassay testing system reagents and consumables for VITROS 7600 laboratory equipment.
Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the internationally headquartered Ortho Clinical Diagnostics, is the primary supplier of laboratory diagnostic materials to the Defense Health Agency and serves multiple U.S. military medical installations throughout the Indo-Pacific region, including naval hospitals in Yokosuka, Atsugi, Sasebo, and Iwakuni, as well as air force bases such as Yokota and Misawa. The company maintains multiple active indefinite-delivery contract vehicles totaling approximately $6.74 million across the Defense Health Agency, Department of Navy Bureau of Medicine and Surgery, and Pacific Air Forces. Performance occurs in Japan and supports critical laboratory diagnostic operations for active duty personnel, dependents, and retirees at U.S. military medical facilities throughout the region.
Quick answers
Who was awarded contract HT941026FE020?
HT941026FE020 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on January 28, 2026.
How much is contract HT941026FE020 worth?
The government has obligated $17,256 on HT941026FE020.
Is contract HT941026FE020 an order under another contract?
Yes. HT941026FE020 is a BPA call under HT941024A0007, a blanket purchase agreement.
Was contract HT941026FE020 competed?
The extent of competition for HT941026FE020 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award